Intraperitoneal cisplatin therapy in ovarian cancer: Comparison with standard intravenous carboplatin and paclitaxel

被引:46
作者
Ozols, Robert F.
Bookman, Michael A.
Young, Robert C.
Du Bois, Andreas
Pfisterer, Jacobus
Reuss, Alexander
机构
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[2] Dr Horst Schmidt Klin, Wiesbaden, Germany
[3] Frauenklin Univ Schleswig Holstein, Kiel, Germany
[4] Univ Marburg, Koordinierungszentrum Klin Stn, Marburg, Germany
关键词
D O I
10.1016/j.ygyno.2006.06.026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1 / 6
页数:6
相关论文
共 22 条
[1]   IMPACT OF DOXORUBICIN ON SURVIVAL IN ADVANCED OVARIAN-CANCER [J].
AHERN, RP ;
GORE, ME .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (03) :726-732
[2]   Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer [J].
Alberts, DS ;
Liu, PY ;
Hannigan, EV ;
OToole, R ;
Williams, SD ;
Young, JA ;
Franklin, EW ;
ClarkePearson, DL ;
Malviya, VK ;
DuBeshter, B ;
Adelson, MD ;
Hoskins, WJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26) :1950-1955
[3]   Intraperitoneal therapy for stage III ovarian cancer: A therapy whose time has come! [J].
Alberts, DS ;
Markman, M ;
Armstrong, D ;
Rothenberg, ML ;
Muggia, F ;
Howell, SB .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (19) :3944-3946
[4]   Intraperitoneal cisplatin and paclitaxel in ovarian cancer [J].
Armstrong, DK ;
Bundy, B ;
Wenzel, L ;
Huang, HQ ;
Baergen, R ;
Lele, S ;
Copeland, LJ ;
Walker, JL ;
Burger, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) :34-43
[5]   Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: A prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group and the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens [J].
du Bois, A ;
Weber, B ;
Rochon, J ;
Meier, W ;
Goupil, A ;
Bricht, S ;
Barats, JC ;
Kuhn, W ;
Orfeuvre, H ;
Wagner, U ;
Richter, B ;
Lueck, HJ ;
Pfisterer, J ;
Costa, S ;
Schroeder, W ;
Kimmig, R ;
Pujade-Lauraine, E .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) :1127-1135
[6]   2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004) [J].
du Bois, A ;
Quinn, M ;
Thigpen, T ;
Vermorken, J ;
Avall-Lundqvist, E ;
Bookman, M ;
Bowtell, D ;
Brady, M ;
Casado, A ;
Cervantes, A ;
Eisenhauer, E ;
Friedlaender, M ;
Fujiwara, K ;
Grenman, S ;
Guastalla, JP ;
Harper, P ;
Hogberg, T ;
Kaye, S ;
Kitchener, H ;
Kristensen, G ;
Mannel, R ;
Meier, W ;
Miller, B ;
Neijt, JP ;
Oza, A ;
Ozols, R ;
Parmar, M ;
Pecorelli, S ;
Pfisterer, J ;
Poveda, A ;
Provencher, D ;
Pujade-Lauraine, E ;
Randall, M ;
Rochon, J ;
Rustin, G ;
Sagae, S ;
Stehman, F ;
Stuart, G ;
Trimble, E ;
Vasey, P ;
Vergote, I ;
Verheijen, R ;
Wagner, U .
ANNALS OF ONCOLOGY, 2005, 16 :7-12
[7]   A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer [J].
du Bois, A ;
Lück, HJ ;
Meier, W ;
Adams, HP ;
Möbus, V ;
Costa, S ;
Bauknecht, T ;
Richter, B ;
Warm, M ;
Schröder, W ;
Olbricht, S ;
Nitz, U ;
Jackisch, C ;
Emons, G ;
Wagner, U ;
Kuhn, W ;
Pfisterer, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (17) :1320-1330
[8]   Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel [J].
Greimel, ER ;
Bjelic-Radisic, V ;
Pfisterer, J ;
Hilpert, F ;
Daghofer, F ;
du Bois, A .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (04) :579-586
[9]   Cancer statistics, 2006 [J].
Jemal, A ;
Siegel, R ;
Ward, E ;
Murray, T ;
Xu, JQ ;
Smigal, C ;
Thun, MJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2006, 56 (02) :106-130
[10]   Intraperitoneal chemotherapy of ovarian cancer: A review, with a focus on practical aspects of treatment [J].
Markman, M ;
Walker, JL .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) :988-994